US Pharma MarketingThe post H1 2026 clinical trials: China, funding and technology set the agenda appeared first on Clinical Trials Arena.
H1 2026 clinical trials: China, funding and technology set the agenda
As the first half of 2026 draws to a close, experts at Arena International’s OCT East Coast reflect on the key trends shaping the sector. As the first half of 2026 draws to a close, experts at Arena International’s OCT East Coast reflect on the key trends shaping the sector. Peter Barschdorff, vice president and head of Deallus, a GlobalData company, presenting at OCT East Coast. Credit: Arena International / Brandon Reynolds As we approach the end of H1, experts have shared their views on the main trends impacting clinical trials in 2026. At Arena International’s Outsourcing in Clinical Trials…
As the first half of 2026 draws to a close, experts at Arena International’s OCT East Coast reflect on the key trends shaping the sector.
Source: Clinical Trials Arena